Repair of DNA double-strand breaks with damaged ends
修复带有受损末端的 DNA 双链断裂
基本信息
- 批准号:8469394
- 负责人:
- 金额:$ 23.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-08-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesBiological AssayBiological FactorsCell ExtractsCellsCytogeneticsDNADNA DamageDNA Double Strand BreakDNA polymerase beta2DNA-Directed DNA PolymeraseDefectDouble Strand Break RepairEmbryoEnzymesExcisionFibroblastsFree RadicalsGenetic EpistasisGenomicsGoalsHumanIn VitroIonizing radiationLabelLeadLigationLinkMalignant NeoplasmsMeasuresMediatingMethylationMethyltransferaseModificationMolecularMusMutationNeurodegenerative DisordersNucleotidesOxidative StressPathway interactionsPeptidesPhasePolymerasePositioning AttributePredispositionProcessProteinsRadiationRadiation induced double strand breakRadiation therapyResearchResolutionRoleSiteSmall Interfering RNASpecificitySystemTOP2A geneTestingTherapeutic IndexTimeTopoisomeraseTopoisomerase InhibitorsWorkartemisbasecancer preventioncancer therapycarcinogenesischemotherapycytotoxicityendonucleaseenzyme pathwayimprovedinhibitor/antagonistkillingslink proteinneoplastic cellnucleaseoverexpressionoxidative damagephosphoglycolaterepair enzymerepairedresearch studytherapeutic targettyrosyl-DNA phosphodiesterase
项目摘要
DESCRIPTION (provided by applicant): Free radical-mediated DNA double-strand breaks (DSBs) induced by ionizing radiation, radiomimetic natural products, and oxidative stress have chemically modified termini such as 32-phosphoglycolates that must be removed before the break can be rejoined. In addition, accurate rejoining of these breaks requires replacement of fragmented nucleotides by gap filling on aligned DSB ends. Radiation-induced DSBs are also often accompanied by nearby oxidative base damage that can interfere with rejoining. DSBs induced by topoisomerase inhibitors have protein-linked termini that likewise must be removed for repair. The overall goal of the proposed project is to determine how these damaged DSB ends are resolved for repair by nonhomologous end joining, and how they affect the overall joining process. Candidate enzymes for processing damaged ends include tyrosyl-DNA phosphodiesterase (TDP1) and the DNA end-specific endonucleases Mre11, Artemis, Metnase and CtIP. Mouse and human cells with genetic defects in Artemis, Metnase, TDP1, Mre11 and combinations thereof will be augmented with siRNA knockdown to generate cells with various combinations of end-processing deficiencies. These cells will be subjected to cytotoxicity, cytogenetic and DSB repair assays, as well as a newly developed real-time PCR assay for measuring the persistence of blocked termini in cells. These studies will determine whether these repair factors provide alternative pathways for resolving blocked DNA termini, and the degree of overlap between them. Defined DSB substrates, bearing ends with 32-phosphoglycolates or oxidatively modified bases in various contexts, will be used to determine the specificities of Artemis and Metnase in trimming damaged ends. The efficiency with which the resulting trimmed ends progress to the gap filling and ligation steps in cell extracts will be determined. Tolerance for damaged bases in gap-filling on aligned DSB ends by DNA polymerase ; will be determined, as well as the possible cooperation and competition between polymerase ; and Artemis in resolving different types of damaged DNA termini.
描述(由申请方提供):电离辐射、拟放射性天然产物和氧化应激诱导的自由基介导的DNA双链断裂(DSB)具有化学修饰的末端,如32-磷酸乙醇酸酯,在断裂重新连接之前必须去除。此外,这些断裂的准确重新连接需要通过对齐的DSB末端上的缺口填充来替换片段化的核苷酸。辐射诱导的DSB也经常伴随着附近的氧化性碱基损伤,这可能会干扰重新连接。由拓扑异构酶抑制剂诱导的DSB具有蛋白质连接的末端,其同样必须被移除以进行修复。拟议项目的总体目标是确定这些受损的DSB末端如何通过非同源末端连接进行修复,以及它们如何影响整个连接过程。用于处理受损末端的候选酶包括酪氨酰-DNA磷酸二酯酶(TDP 1)和DNA末端特异性内切核酸酶Mre 11、Artemis、Metnase和CtIP。在Artemis、Metnase、TDP 1、Mre 11及其组合中具有遗传缺陷的小鼠和人细胞将用siRNA敲低增强,以产生具有末端加工缺陷的各种组合的细胞。这些细胞将接受细胞毒性、细胞遗传学和DSB修复试验,以及新开发的实时PCR试验,用于测量细胞中封闭末端的持久性。这些研究将确定这些修复因子是否为解决阻断的DNA末端提供替代途径,以及它们之间的重叠程度。定义的DSB底物,在各种情况下具有32-磷酸乙醇酸酯或氧化修饰的碱基的末端,将用于确定Artemis和Metnase在修剪受损末端中的特异性。将测定所得修剪末端在细胞提取物中进行差距填充和连接步骤的效率。将确定DNA聚合酶在对齐的DSB末端的缺口填充中对受损碱基的耐受性,以及聚合酶和Artemis在解析不同类型的受损DNA末端时可能的合作和竞争。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lawrence F Povirk其他文献
Regulation and mechanisms of mammalian double-strand break repair
哺乳动物双链断裂修复的调控与机制
- DOI:
10.1038/sj.onc.1206679 - 发表时间:
2003-08-28 - 期刊:
- 影响因子:7.300
- 作者:
Kristoffer Valerie;Lawrence F Povirk - 通讯作者:
Lawrence F Povirk
Lawrence F Povirk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lawrence F Povirk', 18)}}的其他基金
Tyrosyl-DNA phosphodiesterase and oxidative DNA damage
酪氨酰 DNA 磷酸二酯酶和氧化 DNA 损伤
- 批准号:
7440250 - 财政年份:2004
- 资助金额:
$ 23.3万 - 项目类别:
Tyrosyl-DNA phosphodiesterase and oxidative DNA damage
酪氨酰 DNA 磷酸二酯酶和氧化 DNA 损伤
- 批准号:
6893389 - 财政年份:2004
- 资助金额:
$ 23.3万 - 项目类别:
Tyrosyl-DNA phosphodiesterase and oxidative DNA damage
酪氨酰 DNA 磷酸二酯酶和氧化 DNA 损伤
- 批准号:
7092128 - 财政年份:2004
- 资助金额:
$ 23.3万 - 项目类别:
Tyrosyl-DNA phosphodiesterase and oxidative DNA damage
酪氨酰 DNA 磷酸二酯酶和氧化 DNA 损伤
- 批准号:
7243375 - 财政年份:2004
- 资助金额:
$ 23.3万 - 项目类别:
Tyrosyl-DNA phosphodiesterase and oxidative DNA damage
酪氨酰 DNA 磷酸二酯酶和氧化 DNA 损伤
- 批准号:
6761269 - 财政年份:2004
- 资助金额:
$ 23.3万 - 项目类别:
GENOTOXICITY OF DNA DIRECTED ANTINEOPLASTIC AGENTS
DNA 定向抗肿瘤药物的基因毒性
- 批准号:
2090289 - 财政年份:1985
- 资助金额:
$ 23.3万 - 项目类别:
GENOTOXICITY OF DNA-DIRECTED ANTINEOPLASTIC AGENTS
DNA 定向抗肿瘤药物的基因毒性
- 批准号:
3180858 - 财政年份:1985
- 资助金额:
$ 23.3万 - 项目类别:
GENOTOXICITY OF ANTINEOPLASTIC DNA-CLEAVING AGENTS
抗肿瘤 DNA 切割剂的基因毒性
- 批准号:
6447014 - 财政年份:1985
- 资助金额:
$ 23.3万 - 项目类别:
Repair of DNA double-strand breaks with damaged ends
修复带有受损末端的 DNA 双链断裂
- 批准号:
7425000 - 财政年份:1985
- 资助金额:
$ 23.3万 - 项目类别:
GENOTOXICITY OF DNA-DIRECTED ANTINEOPLASTIC AGENTS
DNA 定向抗肿瘤药物的基因毒性
- 批准号:
3180855 - 财政年份:1985
- 资助金额:
$ 23.3万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 23.3万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 23.3万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 23.3万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 23.3万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 23.3万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 23.3万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 23.3万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 23.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 23.3万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 23.3万 - 项目类别:














{{item.name}}会员




